Pharmacokinetic-driven phase I study of DCC-2618 a pan-KIT and PDGFR inhibitor in patients (pts) with gastrointestinal stromal tumor (GIST) and other solid tumors.-MedSci.cn

Pharmacokinetic-driven phase I study of DCC-2618 a pan-KIT and PDGFR inhibitor in patients (pts) with gastrointestinal stromal tumor (GIST) and other solid tumors.

Janku, F; Razak, ARA; Gordon, MS; Brooks, DG; Flynn, DL; Kaufman, M; Pitman, J; Smith, BD; Somaiah, N; De Groot, JF; Chen, G; Jennings, J; Salah, S; Westwood, D; Gerstenberger, E; Rosen, O; George, S

JOURNAL OF CLINICAL ONCOLOGY, 2017; 35 ( ):

科室
- - 订阅+
  - 更多科室
工具
服务